Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Novartis Pharmaceuticals
Uwe Reuter; Peter J Goadsby; Michel Lanteri-Minet; Shihua Wen; Peggy Hours-Zesiger; Michel D Ferrari; Jan Klatt